Job details
Job description, work day and responsibilities
Leadership
Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients. Jeffrey M. Dayno, M.D., is President and Chief Executive Officer of Harmony Biosciences. A nationally recognized expert in neuroscience and leader at Harmony Biosciences since the company’s inception, Dr. Dayno is responsible for overseeing the company’s business growth including Harmony’s successful acquisitions of Zynerba Pharmaceuticals in 2023 and Epygenix Therapeutics, Inc. in 2024, advancement of Harmony’s clinical development programs, and buildout of the company’s innovative pipeline. He has been the driving force behind Harmony’s patient-focused drug development model, which uses patient insights to inform clinical research programs and building a pipeline focused on potential, next-generation, innovative treatments to help people living with rare neurological diseases and unmet medical needs.
Harmony Biosciences is hiring for this role on CareerPlace.
Apply on the company website through Harmony Biosciences.
Imported from employer careers page. Source ref: 5c8c803c3593.
